Markets:

Overview

News

Currencies

International

Treasuries

Inspire Medical Systems, Inc. Common Stock (NY:INSP)

92.27 +0.04 (+0.04%)

Official Closing Price Updated: 7:00 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Inspire Medical Systems, Inc. Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Preview: Inspire Medical Systems's Earnings ↗

February 06, 2023

Via Benzinga

What 5 Analyst Ratings Have To Say About Inspire Medical Systems ↗

January 31, 2023

Via Benzinga

The Ultimate Growth Stocks to Buy With $300 Right Now ↗

January 29, 2023

These three companies should deliver inflation-busting long-term growth.

Via The Motley Fool

Analyst Ratings for Inspire Medical Systems ↗

January 13, 2023

Via Benzinga

Why These 7 Healthcare Stocks Could Soar in 2023 ↗

January 02, 2023

These healthcare stocks to buy are trading at a hefty discount and are poised to deliver robust returns in 2023.

Via InvestorPlace

The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond ↗

December 18, 2022

These seven hottest healthcare stocks have strong growth catalysts that could send each of them higher over the next few years.

Via InvestorPlace

Inspire Medical Systems: Q1 Earnings Insights ↗

May 03, 2022

Inspire Medical Systems (NYSE:INSP) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2022 ↗

December 13, 2022

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 01, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Inspire Medical Systems's Return On Capital Employed Insights ↗

November 09, 2022

Inspire Medical Systems (NYSE:INSP) brought in sales totaling $109.19 million during Q3 according to data provided by Benzinga Pro. However, earnings decreased 16.27%, resulting in a loss of $16.85...

Via Benzinga

United Therapeutics, Super Micro Computer, Novo Nordisk And Other Big Gainers From Wednesday ↗

November 03, 2022

U.S. stocks closed lower on Wednesday, with the Dow Jones dropping more than 500 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Earnings Preview For Inspire Medical Systems ↗

October 31, 2022

Inspire Medical Systems (NYSE:INSP) is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Inspire Medical Systems: Q2 Earnings Insights ↗

August 02, 2022

Inspire Medical Systems (NYSE:INSP) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

Inspire Medical Systems Earnings Preview ↗

August 01, 2022

Inspire Medical Systems (NYSE:INSP) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Inspire Medical Systems's Earnings Outlook ↗

May 02, 2022

Inspire Medical Systems (NYSE:INSP) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Inspire Medical Systems Stock Scores Relative Strength Rating Upgrade ↗

April 20, 2022

Inspire Medical System stock reached an key technical benchmark, seeing its Relative Strength (RS) Rating jumping to 91.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022 ↗

April 13, 2022

Upgrades

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022 ↗

April 06, 2022

Upgrades

Via Benzinga

Executive Chairman Bill Ford Continues To Buy More Ford Shares ↗

April 04, 2022

I was recently listening to Barry’s Ritholtz’s Masters in Business podcast interview with Darren Palmer, the VP of Ford’s Global EV Program, and he...

Via Benzinga

Executives Sell Over $640M Of 5 Stocks ↗

March 30, 2022

Although oil futures traded higher on Wednesday, there were a few notable insider trades. When insiders sell shares, it indicates their concern in the company’s prospects...

Via Benzinga

Inspire Medical Clocks 70% Increase In Q4 Sales, Issues FY22 Guidance Ahead Of Consensus ↗

February 09, 2022

Inspire Medical Systems Inc (NYSE: INSP) generated revenue of

Via Benzinga

Inspire Medical Systems: Q4 Earnings Insights ↗

February 08, 2022

Inspire Medical Systems (NYSE:INSP) reported its Q4 earnings results on Tuesday, February 8, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar ↗

February 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets ↗

January 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Annexon Announces Mixed Phase 2 Data From Huntington Disease Trial Annexon,...

Via Benzinga

Earnings Scheduled For February 8, 2022 ↗

February 08, 2022

Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.

Via Benzinga

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More ↗

February 06, 2022

Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...

Via Benzinga

Inspire Medical Expects Strong Q4 FY21 Revenue Growth ↗

January 05, 2022

Inspire Medical Systems Inc (NYSE: INSP) expects Q4 FY21 revenue of $78.0 million - $78.4 million, up approximately 70% Y/Y and surpassing the consensus estimate of $65...

Via Benzinga

A Peek Into The Markets: US Stock Futures Mixed After Dow Records Another High ↗

January 05, 2022

Pre-open movers U.S. stock futures traded mixed in early pre-market trade after the Dow Jones surged to a new record closing high on Tuesday. Investors are awaiting earnings...

Via Benzinga

5 Stocks To Watch For January 5, 2022 ↗

January 05, 2022

Some of the stocks that may grab investor focus today are: Wall Street expects RPM International Inc. (NYSE: RPM) to report quarterly earnings at $0.83 per share on revenue of...

Via Benzinga

Atrial Fibrillation Market Is Expected To Reach $11.123 Billion At A CAGR 11.2 % Through 2023

November 04, 2021

Palm Beach, FL – November 4, 2021 – FinancialNewsMedia.com News Commentary – Atrial fibrillation is an ailment in which the heart beats irregularly, unlike the usual heartbeat. The upper chambers of...

Via FinancialNewsMedia

Topics Death

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.